$261 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 60 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 114.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | Buy | BIOGEN INC | $20,618,000 | +10.3% | 75,408 | +14.4% | 7.89% | -6.3% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $17,482,000 | +46.8% | 45,130 | +39.2% | 6.69% | +24.7% |
| INCY | Buy | INCYTE CORP | $17,040,000 | +115.8% | 127,475 | +61.8% | 6.52% | +83.3% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $13,397,000 | +72.2% | 122,522 | +16.1% | 5.13% | +46.3% |
| ILMN | Buy | ILLUMINA INC | $9,836,000 | +37.3% | 57,641 | +3.0% | 3.76% | +16.7% |
| AKAOQ | New | ACHAOGEN INC | $7,065,000 | – | 280,038 | +100.0% | 2.70% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICALS INC | $6,818,000 | +8.8% | 77,666 | +2.6% | 2.61% | -7.5% |
| SUPN | New | SUPERNUS PHARMACEUTICALS INC | $6,250,000 | – | 200,000 | +100.0% | 2.39% | – |
| BMY | New | BRISTOL MYERS SQUIBB CO | $5,329,000 | – | 98,000 | +100.0% | 2.04% | – |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $4,636,000 | +710.5% | 358,000 | +517.2% | 1.78% | +588.0% |
| XLRN | Buy | ACCELERON PHARMA INC | $4,514,000 | +850.3% | 170,606 | +816.9% | 1.73% | +707.5% |
| KITE | Buy | KITE PHARMA INC | $4,346,000 | +165.5% | 55,500 | +52.1% | 1.66% | +125.8% |
| SGEN | New | SEATTLE GENETICS INC | $4,086,000 | – | 65,000 | +100.0% | 1.56% | – |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $3,918,000 | +97.5% | 27,000 | +48.4% | 1.50% | +67.8% |
| DERM | Buy | DERMIRA INC | $3,579,000 | +162.4% | 105,000 | +133.3% | 1.37% | +123.1% |
| Buy | NEURODERM LTD | $2,869,000 | +99.7% | 108,248 | +66.5% | 1.10% | +69.7% | |
| STML | New | STEMLINE THERAPEUTICS | $2,805,000 | – | 330,000 | +100.0% | 1.07% | – |
| ANAB | New | ANAPTYS BIO INC | $2,789,000 | – | 100,500 | +100.0% | 1.07% | – |
| BGNE | New | BEIGENE LTDsponsored adr | $2,419,000 | – | 66,041 | +100.0% | 0.93% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $2,134,000 | – | 58,000 | +100.0% | 0.82% | – |
| IONS | New | IONIS PHARMACEUTICALS INC | $2,070,000 | – | 51,500 | +100.0% | 0.79% | – |
| VCYT | New | VERACYTE INC | $1,559,000 | – | 170,000 | +100.0% | 0.60% | – |
| CHRS | New | COHERUS BIOSCIENCES INC | $1,308,000 | – | 62,000 | +100.0% | 0.50% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $1,168,000 | – | 20,000 | +100.0% | 0.45% | – |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $1,113,000 | +32.8% | 9,200 | +22.7% | 0.43% | +13.0% |
| CALA | New | CALITHERA BIOSCIENCES INC | $1,078,000 | – | 93,299 | +100.0% | 0.41% | – |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $1,019,000 | – | 26,000 | +100.0% | 0.39% | – |
| New | MERUS NV | $803,000 | – | 33,104 | +100.0% | 0.31% | – | |
| PCRX | New | PACIRA PHARMACEUTICALS INC | $729,000 | – | 16,000 | +100.0% | 0.28% | – |
| ARRY | Buy | ARRAY BIOPHARMA INC | $693,000 | +21.4% | 77,500 | +19.2% | 0.26% | +3.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-03-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.